Trade Olema Pharmaceuticals, Inc. - OLMA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.08 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.48 |
| Open | 5.49 |
| 1-Year Change | -51.24% |
| Day's Range | 5.44 - 5.62 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 5.48 | -0.15 | -2.66% | 5.63 | 5.89 | 5.45 |
| Jan 17, 2025 | 5.62 | 0.40 | 7.66% | 5.22 | 5.74 | 5.19 |
| Jan 16, 2025 | 5.23 | -0.22 | -4.04% | 5.45 | 5.77 | 5.17 |
| Jan 15, 2025 | 5.47 | 0.31 | 6.01% | 5.16 | 5.49 | 5.15 |
| Jan 14, 2025 | 5.09 | -0.17 | -3.23% | 5.26 | 5.26 | 4.75 |
| Jan 13, 2025 | 4.79 | -0.08 | -1.64% | 4.87 | 4.94 | 4.55 |
| Jan 10, 2025 | 4.99 | -0.49 | -8.94% | 5.48 | 5.52 | 4.89 |
| Jan 8, 2025 | 5.71 | 0.50 | 9.60% | 5.21 | 5.89 | 5.07 |
| Jan 7, 2025 | 5.20 | -0.17 | -3.17% | 5.37 | 5.49 | 5.02 |
| Jan 6, 2025 | 5.46 | -0.41 | -6.98% | 5.87 | 5.90 | 5.44 |
| Jan 3, 2025 | 5.86 | 0.30 | 5.40% | 5.56 | 5.95 | 5.47 |
| Jan 2, 2025 | 5.52 | -0.24 | -4.17% | 5.76 | 6.01 | 5.38 |
| Dec 31, 2024 | 5.79 | 0.23 | 4.14% | 5.56 | 5.93 | 5.54 |
| Dec 30, 2024 | 5.55 | -0.45 | -7.50% | 6.00 | 6.07 | 5.55 |
| Dec 27, 2024 | 6.09 | -0.07 | -1.14% | 6.16 | 6.31 | 6.00 |
| Dec 26, 2024 | 6.26 | 0.06 | 0.97% | 6.20 | 6.33 | 6.15 |
| Dec 24, 2024 | 6.23 | 0.00 | 0.00% | 6.23 | 6.37 | 6.13 |
| Dec 23, 2024 | 6.25 | 0.17 | 2.80% | 6.08 | 6.63 | 6.08 |
| Dec 20, 2024 | 6.06 | 0.40 | 7.07% | 5.66 | 6.17 | 5.64 |
| Dec 19, 2024 | 5.74 | -0.03 | -0.52% | 5.77 | 5.95 | 5.52 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Olema Pharmaceuticals, Inc. Company profile
About Olema Pharmaceuticals Inc
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of targeted therapies for women's cancers. Its lead product candidate, OP-1250, is an oral therapy with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). OP-1250 is an oral small molecule clinical-stage product candidate for the treatment of endocrine-driven cancers. It was designed based on a structural understanding of the ER. OP-1250, both as a monotherapy and in combination with inhibitors of cyclin-dependent kinase four and six (CDK4/6) demonstrated robust tumor shrinkage in several xenograft models, including a breast cancer brain metastasis model. It’s been ongoing Phase 1/2 clinical trial, and in Phase 1b combination with palbociclib, in patients with metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Olema Pharmaceuticals Inc revenues was not reported. Net loss applicable to common stockholders increased from $24M to $71.1M. Higher net loss reflects Research and development increase from $11.7M to $41.8M (expense), Stock-based Compensation in R&D increase from $2M to $9.3M (expense), General and administrative - Balancing increase from $6.7M to $13.8M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
780 Brannan Street
SAN FRANCISCO
CALIFORNIA 94103
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com